Passage BIO (PASG) Profit After Tax (2019 - 2026)

Passage BIO's Profit After Tax history runs 8 years deep, the most recent figure standing at -$7.6 million for Q1 2026.

• In Q1 2026, Profit After Tax rose 50.69% year-over-year to -$7.6 million; the TTM figure through Mar 2026 stood at -$37.7 million (up 40.57% YoY), while the FY2025 annual figure was -$45.5 million, up 29.7% from the prior year.
• Profit After Tax for Q1 2026 stood at -$7.6 million, up from -$13.0 million in the prior quarter.
• The five-year high for Profit After Tax was -$7.6 million in Q1 2026, with the low at -$42.8 million in Q1 2022.
• The 5-year median for Profit After Tax is -$17.5 million (2023), against an average of -$21.0 million.
• The sharpest annual moves came in 2022 and 2025: Profit After Tax decreased 10.12% in 2022, then surged 59.93% in 2025.
• Passage BIO's Profit After Tax stood at -$27.1 million in 2022, then surged by 35.24% to -$17.5 million in 2023, then gained by 27.42% to -$12.7 million in 2024, then decreased by 2.03% to -$13.0 million in 2025, then soared by 41.46% to -$7.6 million in 2026.
• Business Quant data shows PASG's Profit After Tax at -$7.6 million in Q1 2026, -$13.0 million in Q4 2025, and -$7.7 million in Q3 2025.